7TM Pharma Advances the Next First-in-class Obesity Compound Into Clinical Development

7TM Pharma has initiated a phase I/II clinical trial for TM30339, selected from the company’s novel development program for treatment of obesity. TM30339 is the second clinical development candidate taken into clinical testing from the company’s in-house drug discovery programs.